The insider cluster is small relative to market cap and likely reflects routine portfolio diversification post-earnings. Monitor for any additional insider sales or a Form 144 filing that could signal a larger planned disposition. The next catalyst for MANE is the Phase 2 data readout for VDPHL01 in female pattern hair loss, expected in 2H26 — this cluster does not change that timeline.
Price Chart
Executive Summary
CEO Reid Alexander and Director John Childs sold a combined $2.82M in open-market MANE shares within a week of Veradermics' Q2 2026 earnings report, which showed a widening net loss and no revenue. While the CEO's sales include a portion tied to derivative exercises (non-cash), the total open-market sales of ~$2.82M represent ~0.06% of the $4.5B market cap, falling below the 0.1% materiality threshold.
Key Financial Metrics
Key Facts
- CEO Reid Alexander sold 67,500 shares open-market for ~$7.28M across multiple trades on 2026-08-17.
- Director John Childs sold 15,000 shares open-market for ~$1.59M on 2026-08-12.
- Total open-market sales in the cluster: ~$2.82M, representing ~0.06% of MANE's $4.5B market cap.
- The cluster occurred 6 days after Veradermics reported Q2 2026 earnings (widening net loss, no revenue, strong cash position).
- CEO's sales include 3,452 shares exercised from derivatives (non-cash) and 3,452 shares sold at $0 (non-cash).
Financial Impact
Total open-market sales of ~$2.82M, or ~0.06% of market cap — trivial relative to company size.
Risk Factors
- Insider sales may continue if the CEO or directors have additional shares to sell under 10b5-1 plans.
- The company has no revenue and widening losses, making it dependent on clinical trial success for stock appreciation.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-MANE-1787101520044 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 8d ago | 8-K | $122.28 $137.39 | ▲ +12.36% | ▲ +12.50% | $140.72 (+15.08%) |
Oct 13, 2026 14d ago | SC 13G | $116.26 $127.11 | ▲ +9.33% | ▲ +10.48% | $140.72 (+21.04%) |
Aug 21, 2026 9w ago | Insider Cluster | $98.46 $98.41 | ▲ +0.05% | ▲ +0.52% | $140.72 (−42.92%) |
Aug 20, 2026 9w ago | 3 | $102.82 $97.93 | ▼ −4.76% | ▼ −5.23% | $140.72 (+36.86%) |
Aug 18, 2026 10w ago | Insider Cluster | $111.23 $102.80 | ▼ −7.58% | ▼ −7.19% | $140.72 (+26.51%) |
Aug 11, 2026 11w ago | 8-K | $110.75 $111.31 | ▲ +0.51% | ▲ +0.91% | $140.72 (+27.06%) |
Aug 7, 2026 11w ago | S-1 | $110.75 $108.22 | ▲ +2.28% | ▲ +2.24% | $140.72 (−27.06%) |
Aug 7, 2026 11w ago | Institutional Cluster | $114.39 $112.71 | ▼ −1.47% | ▼ −1.87% | $140.72 (+23.02%) |
Jul 15, 2026 14w ago | 8-K | $123.70 $109.85 | ▼ −11.20% | ▼ −10.22% | $140.72 (+13.76%) |
May 12, 2026 24w ago | 8-K | $103.90 $100.38 | ▼ −3.39% | ▼ −3.47% | $140.72 (+35.44%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers